Rhythm Pharmaceuticals Cash Flow Statement (2016-2026) | RYTM

Cash Flow Statement Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-35.39M-35.11M-50.85M-52.53M-44.87M-40.86M-42.49M-52.18M-46.70M-44.16M-41.63M-141.37M-32.26M-43.69M-43.33M-49.52M-46.59M-52.90M-47.51M-55.64M
Share-based Compensation (Quarter)
5.67M5.27M4.68M4.61M5.14M4.80M5.29M6.38M8.89M8.61M8.67M7.77M10.36M11.00M10.56M12.86M15.88M18.81M19.27M23.10M
Deferred Taxes (Quarter)
-5.02M-8.99M
Gains from Sales and Divestitures (Quarter)
0.03M0.16M0.21M
Gains from Investment Securities (Quarter)
0.98M0.96M1.28M1.00M0.91M1.37M-0.00M0.10M0.30M1.32M0.00M-1.20M1.89M1.87M3.16M1.26M3.12M3.12M0.19M8.46M
Non-cash Items (Quarter)
3.21M73.99M3.94M4.58M
Cash from Operations (Quarter)
-31.84M-40.16M-40.47M-53.63M-38.81M-46.99M-34.00M-36.43M-41.09M-29.25M-29.38M-40.74M-29.08M-25.21M-18.84M-40.35M-23.31M-26.62M-25.39M-44.19M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.32M0.32M
Change in Working Capital
Change in Receivables (Quarter)
0.60M2.90M1.89M5.71M0.71M0.33M-0.17M2.90M1.71M-0.79M-0.69M7.83M6.60M-6.17M8.11M
Change in Inventory (Quarter)
-0.01M1.23M2.57M0.69M1.58M0.86M-0.12M3.49M1.90M4.85M0.57M-0.48M2.45M4.93M3.09M
Change in Accured Expenses (Quarter)
5.67M5.99M12.92M-0.05M-1.55M-12.57M15.71M5.17M0.66M4.09M4.86M-1.25M0.48M7.51M15.18M-3.63M13.26M11.02M1.25M-5.62M
Other Working Capital Changes (Quarter)
3.02M-2.96M4.93M-0.95M1.97M-3.83M2.31M-2.15M2.01M-2.73M2.42M-2.71M0.11M0.18M-1.29M11.29M-6.38M2.71M0.49M
Investing Activities
Capital Expenditures (Quarter)
0.25M0.11M0.07M0.13M0.06M0.10M-0.00M0.05M0.00M-0.00M
Change in Intangibles (Quarter)
4.52M0.88M0.27M40.00M0.50M
Change in Acquisitions & Divestments (Quarter)
83.70M156.66M69.05M112.13M51.00M61.48M59.64M92.67M124.50M74.50M63.29M70.05M57.75M45.30M87.53M58.33M80.99M61.50M51.65M99.25M
Cash from Investing Activities (Quarter)
13.53M62.78M7.25M72.52M35.98M-39.70M-40.77M18.46M48.19M-94.96M22.64M30.05M-8.56M-90.82M21.16M24.81M54.03M-246.35M30.35M57.05M
Financing Activities
Cash from Financing Activities (Quarter)
0.38M0.41M0.10M0.40M37.50M158.56M17.36M-0.13M-0.96M73.04M2.42M4.24M146.18M2.49M38.33M32.50M-0.89M189.30M-2.95M-5.40M
Additional items
Exchange Rate Effect (Quarter)
0.09M-0.11M0.08M-0.19M-0.07M-0.30M-0.60M0.98M-0.00M-0.28M0.30M0.06M0.45M
Change in Cash (Quarter)
-17.93M23.03M-33.12M19.29M34.67M71.88M-57.41M-18.02M6.02M-51.09M-4.51M-6.52M108.24M-114.14M41.62M16.96M29.55M-83.36M2.07M7.92M
Free Cash Flow (Quarter)
-32.09M-40.27M-40.54M-53.76M-38.87M-47.08M-34.00M-36.48M-41.09M-29.25M-29.38M-40.74M-29.08M-25.21M-18.84M-40.35M-23.31M-26.62M-25.39M-44.19M
Net Cash Flow (Quarter)
-17.93M23.03M-33.12M19.29M34.67M71.88M-57.41M-18.10M6.14M-51.17M-4.32M-6.45M108.54M-113.54M40.64M16.96M29.83M-83.67M2.01M7.47M